chr16-67174658-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000568146.1(NOL3):c.323C>A(p.Ala108Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000571 in 1,577,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000568146.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NOL3 | NM_001276309.3 | c.333C>A | p.Gly111= | synonymous_variant | 3/4 | ENST00000564992.2 | |
NOL3 | XM_047434851.1 | c.519C>A | p.Gly173= | synonymous_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NOL3 | ENST00000564992.2 | c.333C>A | p.Gly111= | synonymous_variant | 3/4 | 2 | NM_001276309.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152270Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000233 AC: 5AN: 214326Hom.: 0 AF XY: 0.00000856 AC XY: 1AN XY: 116856
GnomAD4 exome AF: 0.00000421 AC: 6AN: 1424782Hom.: 0 Cov.: 32 AF XY: 0.00000142 AC XY: 1AN XY: 705972
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2023 | The c.323C>A (p.A108D) alteration is located in exon 3 (coding exon 2) of the NOL3 gene. This alteration results from a C to A substitution at nucleotide position 323, causing the alanine (A) at amino acid position 108 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at